CJC-1295 without DAC 5mg

CJC-1295 without DAC, also referenced in the literature as Modified GRF 1-29, is a 30-amino-acid growth hormone-releasing hormone (GHRH) analog stabilised against enzymatic degradation but without the albumin-binding DAC moiety. Its short half-life produces a pulsatile GH-release profile that more closely approximates endogenous somatotropic signalling, making it a frequent reference compound in GHRH receptor and pituitary-response studies. The 5mg presentation supports targeted pulsatile-release research.

Supplied as a lyophilised peptide vial, supplied for reconstitution with bacteriostatic water. The 5mg size suits short-interval dosing protocols, GH-pulse characterisation studies and pilot work investigating combined GHRH/GHRP synergy.

Research Applications • Pulsatile growth hormone release profile characterisation • GHRH receptor binding affinity and downstream signalling studies • Pituitary somatotroph response and feedback-loop investigation • Combined GHRH and GHRP synergistic-release research models

Specification • Identity: CJC-1295 no-DAC / Mod GRF 1-29 (CAS 863288-34-0) • Molecular weight: 3367.94 g/mol • Purity: 99%+ verified by HPLC and Mass Spectrometry • Format: lyophilised peptide vial — reconstitute with bacteriostatic water before use • Storage: store lyophilised at -20°C; once reconstituted, refrigerate at 2-8°C and use within 4-6 weeks; protect from light

For research use only — not for human consumption.